Skip to main content
Article

CLINICAL AND PHARMACOLOGICAL AUDIT OF HEPATOPROTECTORS USED IN TREATMENT OF PATIENTS WITH CHRONIC LIVER DISEASES IN SOME HOSPITALS OF KHOREZM REGION - URGENCH BRANCH OF TASHKENT MEDICAL ACADEMY

Ismoilov Solay RuzmamatovichProfessor, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, UzbekistanBekchanova Yulduzkhon KhayitboyevnaSenior Lecturer, Ph. D, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, UzbekistanOmonova Gavkhar SultanovnaSenior Lecturer, Ph. D, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, UzbekistanKarimova Dilbar SharipovnaSenior Lecturer, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, UzbekistanAkhmedova Nazokat MarimbaevnaAssistant, Department of Pharmacology and Clinical Pharmacology, Al-Khorazmiy St 28, Urgench City, Uzbekistan
ABI

Abstract

<strong>Abstract</strong> Retrospectively, pharmacoepidemiological methods were used to study 360 pieces of the history of diseases of patients with diseases of the hepatobiliary system, treated in the central polyclinic of the city of Urganch and the Khiva district medical association. For the study, the questionnaire included 35 names of hepatoprotectors used in practical medicine in Uzbekistan. It was revealed that pharmacotherapy of patients with hepatobiliary diseases in the central polyclinic of the city of Urganch and Khiva district medical association is adequate for the severity of the pathological process and corresponds to the recommendations recognized by the global community of gastroenterologists. In the treatment of patients with diseases of the hepatobiliary system, physicians used hepatoprotectors separately, as well as in a combined form.

Topics

Identifiers

Citations and references

Cited by 00 references